Skip to content

apixaban in radial artery occlusion

Evaluating the effects of apixaban on re-opening of radial artery occlusion following cardiac catheterization through radial artery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120111008698N25
Enrollment
50
Registered
2021-04-15
Start date
2020-09-22
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease, acute coronary syndrome, unstable angina, chronic coronary syndrome.

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients over 18 years who are candidates for coronary angiography or angioplasty through radial artery approach

Exclusion criteria

Exclusion criteria: contraindication for apixaban, or high bleeding risk liver failure ( child pugh C) chronic kidney disease GFR <30 ml/ min anemia Hgb < 10 g/dl patients on anti coagulation medication for other purposes patients on CYP3A4 , P-glycoprotein inhibitors Antiphospholipid Antibody Syndrome not willing to provide ocnsent

Design outcomes

Secondary

MeasureTime frame
Incidence of MI. Timepoint: after a month. Method of measurement: clinical and para clinical criteria.;Incidence of hemorrhagic stroke. Timepoint: within a week. Method of measurement: clinical criteria.

Primary

MeasureTime frame
Reopening of radial artery occlusion. Timepoint: first day and after one month. Method of measurement: doppler ultrasound.;Incidence of major bleeding. Timepoint: a week after thi inervention. Method of measurement: based on ISTH criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactazin gheymati

Tehran University of Medical Sciences

gheimatiazin@gmail.com+98 21 8860 6620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026